0

Tirapazamine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP27314972
CAS27314-97-2
MDL NumberMFCD00132954
Molecular Weight178.15
InChI KeyORYDPOVDJJZGHQ-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Color, orange to dark orange-red
Formpowder
Size10MG, 50MG
Storage Conditions−20°C
1

Gateways to Clinical Trials

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):159-84.

PMID: 12087878

1

Risk-based Treatment for Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group

Leo Mascarenhas, Elizabeth R Lyden, Philip P Breitfeld, David O Walterhouse, Sarah S Donaldson, David A Rodeberg, David M Parham, James R Anderson, William H Meyer, Douglas S Hawkins

Cancer. 2019 Aug 1;125(15):2602-2609.

PMID: 31067356

1

Tirapazamine: A Bioreductive Anticancer Drug That Exploits Tumour Hypoxia

W A Denny, W R Wilson

Expert Opin Investig Drugs. 2000 Dec;9(12):2889-901.

PMID: 11093359

1

Tirapazamine-cisplatin: The Synergy

U Gatzemeier, G Rodriguez, J Treat, V Miller, R von Roemeling, J Viallet, A Rey

Br J Cancer. 1998 Jun;77 Suppl 4(Suppl 4):15-7.

PMID: 9647615

1

Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy

Yazhe Wang, Ying Xie, Jing Li, Zheng-Hong Peng, Yuri Sheinin, Jianping Zhou, David Oupický

ACS Nano. 2017 Feb 28;11(2):2227-2238.

PMID: 28165223

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode